Cirrhosis of the Liver: Causes, Stages, and Treatment

Roughly 4 to 5 million Americans live with chronic liver disease and cirrhosis, and it ranks among the leading causes of death in the United States, according to the CDC. Cirrhosis represents the end stage of virtually every chronic liver disease – a point where years of damage have replaced healthy liver tissue with scar tissue, compromising the organ’s ability to function. What makes cirrhosis particularly treacherous is that the liver compensates remarkably well for a long time, hiding the damage until a critical threshold is crossed. For a broader view of chronic conditions, see our medical conditions guide.

What Is Cirrhosis?

Cirrhosis is the advanced scarring (fibrosis) of the liver resulting from long-term liver damage. The liver is one of the most resilient organs in the body – it can regenerate, compensate for lost function, and tolerate substantial injury. But when that injury is chronic and ongoing, the regenerative process goes awry. Instead of healthy liver cells, the body lays down dense scar tissue that distorts the liver’s architecture and impedes blood flow through it.

This scarring has two major consequences. First, it reduces the liver’s functional capacity – its ability to process nutrients, produce proteins, detoxify the blood, and make bile. Second, it creates resistance to blood flow through the liver, raising pressure in the portal vein (portal hypertension) and triggering a cascade of potentially life-threatening complications.

The NIDDK notes that cirrhosis is not a single disease but the final common pathway of many different liver diseases. The damage is generally considered irreversible at the cirrhotic stage, though treating the underlying cause can prevent further progression and, in some cases, allow modest improvement in liver function – which is why identifying and addressing the cause is so important.

Causes

Alcohol-associated liver disease has historically been the most recognized cause of cirrhosis. Heavy alcohol use over years causes inflammation (alcohol-associated hepatitis) and progressive fibrosis that can ultimately lead to cirrhosis. Not everyone who drinks heavily develops cirrhosis – genetics, nutrition, sex, and co-existing liver conditions influence susceptibility – but sustained heavy drinking substantially increases risk, and women tend to develop damage at lower amounts than men.

MASLD and MASH. In 2023, liver societies worldwide replaced the older terms “nonalcoholic fatty liver disease (NAFLD)” and “nonalcoholic steatohepatitis (NASH)” with new nomenclature: metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive, inflammatory form, metabolic dysfunction-associated steatohepatitis (MASH). (A related category, MetALD, describes people with both metabolic risk factors and higher alcohol intake.) MASH is among the fastest-growing causes of cirrhosis and a leading indication for liver transplantation. It is driven by the same metabolic factors as type 2 diabetes and obesity, and it is closely tied to fatty liver disease. You may still see the older NAFLD/NASH terms in some materials, but MASLD/MASH is the current standard.

Chronic viral hepatitis. Chronic hepatitis C was for decades a leading cause of cirrhosis and liver transplantation. Direct-acting antiviral medications now cure hepatitis C in well over 95% of patients, which has been transformative – but many people with hepatitis C remain undiagnosed, and those who are already cirrhotic still face ongoing risks even after cure. Chronic hepatitis B causes cirrhosis primarily where it is endemic; antiviral treatment can suppress the virus and slow or prevent progression.

Other causes include autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, hemochromatosis (iron overload), Wilson’s disease (copper overload), certain cardiac and vascular conditions, and drug- or supplement-induced liver injury. According to the Mayo Clinic, in some cases no cause is ever identified (cryptogenic cirrhosis), though many such cases are now attributed to unrecognized metabolic disease.

Stages: Compensated vs. Decompensated

The clinical course of cirrhosis is divided into two broad stages with dramatically different implications. Compensated cirrhosis means the liver, despite significant scarring, is still functioning well enough to perform its essential tasks. People with compensated cirrhosis may have no symptoms at all and can remain in this stage for years or even decades; median survival in compensated disease is often cited at more than a decade.

Decompensated cirrhosis occurs when the liver can no longer compensate and complications develop. The hallmark events marking decompensation include ascites (fluid accumulation in the abdomen), variceal bleeding (rupture of swollen veins in the esophagus or stomach), hepatic encephalopathy (confusion and altered mental status from toxin buildup), and jaundice (yellowing of the skin and eyes). Once decompensation occurs, median survival drops substantially – often to around two years – without liver transplantation, which is why preventing decompensation is a central goal.

The Model for End-Stage Liver Disease (MELD) score – based on bilirubin, creatinine, sodium, and INR (a measure of blood clotting) – is used to assess disease severity and prioritize patients for liver transplantation. Higher MELD scores indicate more severe disease and higher short-term mortality. The Child-Pugh classification is another widely used prognostic tool. Transplant centers rely on these scores as key tools in decision-making.

Symptoms

In the compensated stage, symptoms are often absent or nonspecific: fatigue, weakness, mild appetite loss, or vague abdominal discomfort. These are easily attributed to other causes, which is why cirrhosis is frequently discovered during evaluation for something else entirely – an abnormal blood test, an imaging study, or a routine physical exam.

As the disease progresses to decompensation, symptoms become more pronounced and harder to ignore. Ascites causes visible abdominal swelling, discomfort, and difficulty breathing when severe. Jaundice turns the skin and whites of the eyes yellow. Easy bruising and bleeding occur because the liver cannot produce enough clotting factors. Hepatic encephalopathy causes confusion, personality changes, disorientation, and in severe cases coma.

Other symptoms include intense itching (pruritus), spider-like blood vessels on the skin (spider angiomata), redness of the palms (palmar erythema), swelling of the legs, muscle wasting, enlargement of breast tissue in men (gynecomastia), dark urine, and pale stools. The NIDDK emphasizes that the appearance of any of these signs warrants medical evaluation – and the emergency signs in the red box above warrant immediate care.

Diagnosis

Blood tests often provide the first clues: elevated liver enzymes (though these may be normal in advanced cirrhosis), low albumin, elevated bilirubin, prolonged INR, and low platelet count (thrombocytopenia, caused by portal hypertension and an enlarged spleen). A comprehensive metabolic panel and complete blood count are standard initial tests.

Imaging with ultrasound, CT scan, or MRI can reveal a nodular, shrunken liver, an enlarged spleen, ascites, and a dilated portal vein – all indicators of cirrhosis and portal hypertension. Transient elastography (FibroScan) and related techniques measure liver stiffness non-invasively and can quantify fibrosis, sometimes detecting advanced fibrosis before clinical cirrhosis is apparent. Non-invasive blood-based scores (such as FIB-4) are increasingly used to flag people who need closer evaluation.

Liver biopsy remains a definitive way to confirm cirrhosis, determine the underlying cause, and assess the degree of inflammation and fibrosis, but it is not always necessary when clinical, laboratory, and imaging findings are unambiguous. Upper endoscopy is performed to screen for esophageal and gastric varices – dilated veins that can bleed catastrophically – and is recommended in patients with newly diagnosed cirrhosis who are at risk, following current specialty guidance.

Complications and Their Management

Portal Hypertension and Varices

Scar tissue blocks normal blood flow through the liver, raising pressure in the portal venous system. Blood is forced into alternative routes, creating swollen, fragile veins (varices) in the esophagus, stomach, and elsewhere. Variceal bleeding is a life-threatening emergency. Non-selective beta-blockers and endoscopic band ligation are used to reduce the risk of first and recurrent bleeding, under specialist care. If you vomit blood or pass black, tarry stools, call 911.

Ascites and Spontaneous Bacterial Peritonitis

Ascites – fluid accumulation in the abdominal cavity – is the most common complication of cirrhosis. It is typically managed with dietary sodium restriction and diuretics, and, when severe or medication-resistant, with large-volume paracentesis (draining the fluid with a needle) for relief. A dangerous complication is spontaneous bacterial peritonitis (SBP) – infection of the ascitic fluid – which requires prompt antibiotic treatment; new abdominal pain, fever, or worsening confusion in someone with ascites should trigger urgent evaluation. Some patients are placed on preventive antibiotics by their clinicians.

Hepatic Encephalopathy

When the liver fails to clear toxins – particularly ammonia – from the blood, they reach the brain and cause cognitive dysfunction ranging from subtle concentration difficulties to coma. Treatment commonly includes lactulose (which promotes toxin excretion through the bowel) and, when needed, the antibiotic rifaximin, prescribed and dosed by the care team. The Mayo Clinic notes that hepatic encephalopathy is often reversible with treatment, but new confusion or drowsiness should be evaluated urgently, as it can also be triggered by infection, bleeding, dehydration, or certain medications.

Hepatocellular Carcinoma (Liver Cancer)

Cirrhosis from any cause significantly increases the risk of liver cancer (hepatocellular carcinoma, or HCC). Surveillance with liver ultrasound, usually every six months (sometimes with an alpha-fetoprotein blood test), is recommended for most patients with cirrhosis. Early detection of HCC allows for potentially curative treatments including surgical resection, ablation, and liver transplantation. Keeping up with this every-six-month screening schedule is one of the most important things a person with cirrhosis can do.

Treatment: Addressing the Underlying Cause

The most important treatment for cirrhosis is stopping or controlling the underlying cause. For alcohol-associated cirrhosis, complete abstinence from alcohol is essential and can improve survival even in decompensated disease. For hepatitis B, long-term antiviral therapy suppresses the virus and reduces progression. For hepatitis C, curative antiviral treatment eliminates the virus and can improve fibrosis over time.

For MASH, the cornerstones are weight management, treatment of diabetes and other metabolic risk factors, and lifestyle change. Notably, in 2024 the FDA approved resmetirom (brand name Rezdiffra) – the first medication approved specifically for MASH, indicated (alongside diet and exercise) for adults with noncirrhotic MASH with moderate-to-advanced liver scarring; it is not approved for people who already have decompensated cirrhosis, and whether and how it fits any individual’s care is a decision for a liver specialist. Research into additional MASH therapies is active, and certain metabolic and weight-loss medications are also being studied in this setting. For autoimmune hepatitis, immunosuppressive medications control the inflammation; for hemochromatosis, phlebotomy removes excess iron. In every case, treating the cause – when possible – prevents further damage and gives the liver the best chance of maintaining, or even partly recovering, function.

General liver-protective measures matter too. People with cirrhosis should avoid alcohol entirely, use caution with medications and supplements that can stress the liver, and coordinate all medication decisions with their clinician. Acetaminophen is often considered relatively safe in limited doses in cirrhosis and is frequently preferred over NSAIDs for pain, but the safe daily amount is typically lower than for the general population and must be set by your clinician – and it should be avoided altogether with ongoing alcohol use. Never combine acetaminophen with alcohol.

Liver transplantation is the definitive treatment for end-stage cirrhosis. It offers strong long-term survival – a large majority of recipients survive well beyond five years. Eligibility depends on disease severity (MELD score), the absence of contraindications, and the ability to adhere to post-transplant care. Thousands of liver transplants are performed each year in the United States, though demand continues to exceed the supply of donor organs. Understanding healthcare costs is important when navigating the complex financial landscape of transplant and long-term liver care.

Frequently Asked Questions

Can cirrhosis be reversed?

Advanced cirrhosis with extensive scarring is generally considered irreversible. However, treating the underlying cause can halt progression and, in some cases, allow modest improvement in liver function and even some regression of fibrosis. Early cirrhosis (particularly compensated) has better potential for stabilization. The liver’s regenerative capacity is remarkable but has limits – which is why early detection and treatment of the cause are so critical.

How much alcohol causes cirrhosis?

There is no single threshold that guarantees cirrhosis – susceptibility varies with genetics, sex, body weight, nutrition, and other liver conditions. Risk rises with heavier and longer-duration drinking, and women tend to develop damage at lower amounts than men. Not everyone who drinks heavily develops cirrhosis, but the risk climbs with the amount and duration of use. If you are worried about your drinking, talk with a clinician – support and treatment are available.

Can you live a normal life with cirrhosis?

Many people with compensated cirrhosis live active lives for years. The keys are managing the underlying cause, avoiding further liver injury (especially alcohol and unnecessary or hepatotoxic medications), following surveillance schedules, and maintaining good nutrition. Quality of life can be good in the compensated stage, though it typically declines once decompensation occurs.

What should you eat with cirrhosis?

Nutrition is critical in cirrhosis. A balanced diet with adequate protein helps prevent muscle wasting, which is common. Sodium restriction is important for managing ascites. Small, frequent meals – including a bedtime snack – help maintain nutrition and prevent muscle breakdown overnight. Avoid alcohol completely. A dietitian experienced in liver disease can create an individualized plan; ask your care team for exact protein and sodium targets, since they vary by person and stage.

How long can you live with cirrhosis?

Survival depends heavily on the stage. Compensated cirrhosis often has a median survival of more than a decade. Once decompensation occurs (ascites, variceal bleeding, encephalopathy, or jaundice), median survival is much shorter – often around two years without transplantation. MELD score and the Child-Pugh classification help estimate prognosis. Treating the underlying cause and preventing decompensation are the most impactful factors for survival.

What are the warning signs I need emergency care?

Call 911 for vomiting blood or passing black, tarry stools. Seek urgent or emergency care for new confusion, drowsiness, or disorientation; for abdominal swelling with pain and fever; and for rapidly worsening jaundice. These can reflect life-threatening complications – variceal bleeding, hepatic encephalopathy, spontaneous bacterial peritonitis, or acute liver deterioration – that need immediate treatment.

What You Should Do Now

If you have been diagnosed with cirrhosis, the most important actions are to eliminate the underlying cause (stop drinking, treat hepatitis, manage metabolic risk factors), take all prescribed medications as directed, follow your recommended diet, attend all surveillance appointments (including liver-cancer ultrasound screening, usually every six months, and any recommended endoscopy for varices), and avoid anything that could further injure the liver – particularly alcohol and unnecessary medications. Learn the emergency warning signs above so you can act fast.

If you have risk factors for liver disease – heavy alcohol use, chronic hepatitis B or C, obesity with metabolic syndrome or diabetes, or a family history of liver disease – get screened. Blood tests and non-invasive fibrosis assessment can identify liver damage long before cirrhosis develops, when intervention is most effective. The liver gives you many chances to change course; the key is recognizing and acting on them before the damage becomes irreversible.

Medical disclaimer: This article is general education, not medical advice, and is not a substitute for care from a qualified clinician. Cirrhosis requires individualized management and monitoring by a doctor. Do not start, stop, or change any medication on your own, and seek emergency care for the red-flag symptoms described above.

Sources

• NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases), Cirrhosis – niddk.nih.gov
• Mayo Clinic, Cirrhosis – mayoclinic.org
• CDC, Chronic Liver Disease and Cirrhosis (FastStats) – cdc.gov
• American Association for the Study of Liver Diseases (AASLD), Practice Guidance – aasld.org
• U.S. Food and Drug Administration (FDA), Rezdiffra (resmetirom) – fda.gov